LAVA Medtech Acquisition Corp.
LAVA Medtech Acquisition Corp. (LVAC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lvac · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for LAVA Medtech Acquisition Corp. (LVAC) measures how much investors pay for each dollar of the company's trailing earnings. LVAC's current PE ratio of 33.28x is calculated by dividing its stock price of $10.43 by its TTM earnings per share of $0.31. +64.8% elevated vs 5Y avg 20.2x
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2021 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
LAVA Medtech Acquisition Corp.You LVAC | $150M | 33.28x | -50.7% | $0.31 |
 Blockchain Coinvestors Acquisition Corp. I BCSA | $149M | 31.06x | -54.0% | $0.35 |
 Battery Future Acquisition Corp. BFAC | $154M | 60.28x | -10.7% | $0.18 |
 Beard Energy Transition Acquisition Corp. BRD | $138M | 194.18x | +187.5% | $0.05 |
 Forest Road Acquisition Corp. II FRXB | $138M | 39.02x | -42.2% | $0.26 |
 HH&L Acquisition Co. HHLA | $157M | 13.13x | -80.6% | $0.77 |
 SeaStar Medical Holding Corporation ICU | $8M | N/A | — | -$0.59 |
Industry Average 5 peers with valid PE | — | 67.53x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | 32.52x | $0.31 | +312.7% | |
2021-12-31 FY2021 | 7.88x | $1.25 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for LAVA Medtech Acquisition Corp. (LVAC) measures how much investors pay for each dollar of the company's trailing earnings. LVAC's current PE ratio of 33.28x is calculated by dividing its stock price of $10.43 by its TTM earnings per share of $0.31.
Frequently asked questions
LVAC pe ratio · 6 questionsLVAC's current PE ratio is 33.28x as of 2026-06-09, based on a stock price of $10.43 and TTM EPS of $0.31. Data sourced from Financial Modeling Prep via LVAC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · LAVA Medtech Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09